We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$337M
AUM Growth
+$26M
Cap. Flow
+$70.1M
Cap. Flow %
20.76%
Top 10 Hldgs %
41.52%
Holding
54
New
11
Increased
24
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.4M
2
BBDC icon
Barings BDC
BBDC
+$9.14M
3
SNY icon
Sanofi
SNY
+$8.86M
4
BXSL icon
Blackstone Secured Lending
BXSL
+$8.47M
5
KKR icon
KKR & Co
KKR
+$8.13M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.9M
2
LPLA icon
LPL Financial
LPLA
+$4.57M
3
MO icon
Altria Group
MO
+$4.27M
4
TMUS icon
T-Mobile US
TMUS
+$3.91M
5
CEG icon
Constellation Energy
CEG
+$3.65M

Sector Composition

Rank Sector Weight
1 Financials 48.54%
2 Healthcare 11.66%
3 Real Estate 10.11%
4 Consumer Discretionary 9.13%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTB icon
26
M&T Bank
MTB
$36.1B
$5.58M 1.65%
+35,000
New +$5.88M
ARCC icon
27
Ares Capital
ARCC
$14.1B
$5.36M 1.59%
298,882
+198,882
+199% +$3.92M
SWK icon
28
Stanley Black & Decker
SWK
$15.3B
$5.24M 1.55%
+50,000
New +$6.15M
LEN icon
29
Lennar Class A
LEN
$20.4B
$4.59M 1.36%
+67,145
New +$4.92M
VST icon
30
CALL
Vistra
VST
$47.7B
$4.57M 1.35%
200,000
– –
CCAP icon
31
Crescent Capital BDC
CCAP
$434M
$4.31M 1.28%
277,780
-3,597
-1% -$61.7K
OBDC icon
32
Blue Owl Capital
OBDC
$5.58B
$3.88M 1.15%
315,000
+40,000
+15% +$548K
GEN icon
33
Gen Digital
GEN
$16.8B
$3.84M 1.14%
175,000
+40,000
+30% +$983K
OLN icon
34
Olin
OLN
$2.14B
$3.7M 1.1%
80,000
-25,000
-24% -$1.44M
KSS icon
35
Kohl's
KSS
$2.09B
$3.57M 1.06%
+100,000
New +$4.9M
STLA icon
36
Stellantis
STLA
$20.9B
$3.4M 1.01%
275,000
+50,000
+22% +$707K
CGBD icon
37
Carlyle Secured Lending
CGBD
$741M
$3.17M 0.94%
250,000
-220,000
-47% -$3.09M
SLRC icon
38
SLR Investment Corp
SLRC
$705M
$2.56M 0.76%
175,000
-25,000
-13% -$402K
CCI icon
39
Crown Castle
CCI
$31.9B
$2.53M 0.75%
15,000
+5,000
+50% +$910K
ET icon
40
Energy Transfer Partners
ET
$71.2B
$2.5M 0.74%
250,000
– –
RRGB icon
41
Red Robin
RRGB
$156M
$1.81M 0.54%
+225,000
New +$2.43M
NTG
42
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$1.28M 0.38%
+39,940
New +$1.45M
HP icon
43
Helmerich & Payne
HP
$3.7B
$1.03M 0.31%
23,954
-39,796
-62% -$1.85M
ETR icon
44
Entergy
ETR
$49.7B
$845K 0.25%
+15,000
New +$882K
NEM icon
45
Newmont
NEM
$111B
$753K 0.22%
12,613
-26,831
-68% -$1.9M
BURL icon
46
Burlington
BURL
$23.4B
$681K 0.2%
+5,000
New +$905K
GBDC icon
47
Golub Capital BDC
GBDC
$3.39B
$648K 0.19%
+50,000
New +$716K
EQT icon
48
EQT Corp
EQT
$32.3B
$344K 0.1%
+10,000
New +$412K
SAM icon
49
Boston Beer
SAM
$1.88B
$303K 0.09%
1,000
– –
EAT icon
50
Brinker International
EAT
$9.75B
$294K 0.09%
13,333
– –
1
2
3

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 28.88% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return

Callodine Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Callodine Capital Management held 54 positions worth $337M, up 8.3% from $311M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Callodine Capital Management deployed $70.1M of net new capital in Q2 2022, opening 11 new positions and adding to 24 existing holdings. Its largest new stake was Sanofi: 166,935 shares worth $8.35M.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 45% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $13.9M trimmed.

  • Callodine Capital Management's largest Q2 2022 buy was Sanofi: 166,935 shares worth $8.35M.
  • Callodine Capital Management added most to Merck in Q2 2022, an estimated $12.4M increase.
  • Callodine Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $13.9M.
  • Callodine Capital Management fully exited LPL Financial in Q2 2022, selling an estimated $4.57M.
  • Callodine Capital Management's ten largest holdings make up 42% of its $337M portfolio in Q2 2022.
  • Callodine Capital Management opened 11 new positions and closed 4 in Q2 2022.
  • Callodine Capital Management's portfolio value rose 8.3% quarter-over-quarter to $337M.

Based on Callodine Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.